A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Virginia Commonwealth University Medical Center Main Hospital /ID# 164574, Richmond

Nemours Children's Health System /ID# 164553, Jacksonville

Central FL Pulmonary Orlando /ID# 164558, Orlando

UH Cleveland Medical Center /ID# 206095, Cleveland

Cleveland Clinic Main Campus /ID# 212853, Cleveland

University of Iowa Hospitals and Clinics /ID# 164551, Iowa City

The Cystic Fibrosis Institute /ID# 210757, Northfield

University of Southern California /ID# 164571, Los Angeles

Landon Pediatric Foundation /ID# 215411, Ventura

Via Christi Research /ID# 214266, Wichita

Nationwide Children's Hospital /ID# 225628, Columbus

Children's Hospital of Philadelphia - Main /ID# 208114, Philadelphia

Vanderbilt University Medical Center /ID# 213434, Nashville